34% expert_concordance
Historical MTB agreement with expert oncogenicity reassessment: expert_concordance
- Tested configuration
- Historical Erlangen MTB protein-function interpretation
- Protocol
- OncoVI three-class assessment: MTB selected expert reassessment
- Dataset
- MTB selected expert reassessment
- Procedure
- Not reported
- Evaluation
- Historical MTB agreement with expert oncogenicity reassessment
- Coverage
- scored: unreported; eligible: unreported
- Uncertainty
- Not reported
- Evidence
- Author-reported evaluation · source checkedOncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology · Results, validation data set, paragraph ending 46/135; Figure 4A
A source-checked result verifies the numerical transcription, not every model or protocol detail. Evaluation metadata: source checked. Source checked does not mean independently reproduced.
Reproduction
- Split
- Not reported
- Adaptation
- Not reported
- Scoring implementation
- Source-defined endpoint; see result source_locator
No execution recipe has been verified for this exact configuration and evaluation. A benchmark's general instructions may use different inputs, splits or model settings.
Reproducing this published result requires matching its model configuration, data, split and scorer. Source checking or a successful smoke test does not establish score reproduction.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
1 evidence row matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Reported result 34% Individual claims | Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology Results, validation data set, paragraph ending 46/135; Figure 4A Version: 2026 final full text in Europe PMC XML | source checked automated source review · 2026-09-30 author reported Audit detailsTranscription from inspected primary source. No execution, independent replication or human scientific review. Field: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
View linked audit checks and correction history
Release 2026-09-30-e37e3ab1284d · Record review: source checked
1 source records and release history
- Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology · Original source · 2026 final full text in Europe PMC XML
Technical metadata and extraction receipts
Stable ID: uc-clinical-20260930-oncovi-prior-mtb-expert-agreement
- areas
- dna-genomes
- contexts
- clinical_research
- metric
- expert_concordance
- unit
- percent
- printed value
- 34%
- numeric value
- 34
- metric direction
- higher
- uncertainty
- Not reported
- source locator
- Results, validation data set, paragraph ending 46/135; Figure 4A
- review
- method: automated_source_review; reviewer: Codex clinical coverage worker; date: 2026-09-30; note: Transcription from inspected primary source. No execution, independent replication or human scientific review.; source id: uc-clinical-20260930-source-oncovi
- numerator
- 46
- denominator
- 135
- missing metadata
- uncertainty: not reported for this endpoint